Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
Sheng, Iris Y ; Ornstein, Moshe C
Cancer management and research, 2020-01, Vol.12, p.4871-4881
[Periódico revisado por pares]
New Zealand: Dove
Texto completo disponível